FDA Approved: HERZUMA — Supplemental Application (Cephalon, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Herzuma (trastuzumab) from Cephalon, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• HERZUMA (TRASTUZUMAB)

Snippet

SUPPL AP for HERZUMA (TRASTUZUMAB)